In HIV, Mental Health Impacts Viral Suppression, But Not Retention in Care
People with HIV experience a high prevalence of mental health (MH) conditions and associated...
Read More
Meeting Coverage
HIV Persistence Markers Reduction in ART-Treated Adults by Doubling Dolutegravir Dosage
The following is a summary of “DOUBLING DOLUTEGRAVIR DOSAGE REDUCES HIV PERSISTENCE MARKERS...
Read More
D2EFT: Evaluating Dolutegravir and Darunavir in HIV Therapy Failure
The following is a summary of “D2EFT: DOLUTEGRAVIR AND DARUNAVIR EVALUATION IN ADULTS...
Read More
Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use
NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients A...
Read More
Neuroinflammatory Biomarkers: Linking HIV and Depression
The following is a summary of “(NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION...
Read More
HIV Reservoir’s Impact on Natural Elite Control of HIV-1 Infection
The following is a summary of “IMPACT OF HIV RESERVOIR IN THE LOSS OF NATURAL ELITE CONTROL...
Read More
ASH Lymphoma eBook
Focus on ASH Lymphoma 2023v2.indd
Read More
The Impact of HIV on One-Year Mortality After ICU Admission
The following is a summary of “ONE-YEAR MORTALITY OF PEOPLE WITH HIV AFTER INTENSIVE CARE...
Read More
Estimation of HCC Risk in HIV/HBV Patients Using PAGE-B Score
The following is a summary of “PAGE-B SCORE TO ESTIMATE THE HEPATOCELLULAR CARCINOMA RISK IN...
Read More
Hepatic Resection Linked With Better OS After RT+TACE for HCC With MVI
In HCC with macroscopic vascular invasion, hepatic resection was significantly linked with better...
Read More
CROI 2023 COVID-19 Policy
Here are some highlights of CROI 2023 COVID-19 policy. To attend CROI 2023 in person attendees...
Read More
Looking Forward to CROI 2023 Opening Session
The opening session of CROI 2023 will be streamed live, with open access for all who are...
Read More
What You Don’t Want to Miss at CROI 2023
Key Sessions Welcome from the CROI 2023 Chair Sunday, Feb 19. 5:00-7:20pm Includes “CROI: A...
Read More
Highlights From CROI 2022
Research was presented virtually at CROI 2022, the annual Conference on Retroviruses and...
Read More
Novel Regimen May Avoid TME Surgery in Rectal Cancer
In patients with rectal cancer, neoadjuvant radiotherapy (RT) followed by atezolizumab and...
Read More
IMbrave 151 Missed Primary Endpoint in Advanced BTC
Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...
Read More
New Standard of Care for Colorectal Cancer
The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...
Read More
SWOG 1815, First-Ever Phase 3 Trial in BTC, Fails
The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...
Read More